VNS THERAPY SYSTEM
FDA premarket approval P970003/S040 · decided 2002-06-20
Approval details
- PMA number
- P970003
- Supplement
- S040
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- VNS THERAPY SYSTEM
- Generic name
- Stimulator, autonomic nerve, implanted for epilepsy
- Applicant
- LivaNova USA, Inc.
- Date received
- 2002-04-19
- Decision date
- 2002-06-20
- Days to decision
- 62 days
- Decision code
- APPR
- Product code
- LYJ
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Houston, TX
- Statement
- APPROVAL FOR MODIFICATIONS TO THE EXISTING MODEL 101 (VERSION 2) IN-LINE NCP PULSE GENERATOR AND MODEL 302 (VERSION 1) IN-LINE NCP BIPOLAR LEAD, RESULTING IN THE NEW VNS THERAPY PULSE, MODEL 102 GENERATOR AND THE VNS THERAPY LEAD, MODEL 302 (VERSION 1.1). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME VNS THERAPY SYSTEM.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Venous Return Cannulae (K250937) | LivaNova USA, Inc. | 2026-03-11 |
| RAP Femoral Venous Cannulae (K250283) | LivaNova USA, Inc. | 2025-07-10 |
| SMARxT Tubing and Connectors (K233702) | LivaNova USA, Inc. | 2024-08-08 |